Interleukin-2 (IL-2) Market to Grow Rapidly Over the Next Decade by 2034, DelveInsight Observes

Interleukin-2 Market Size, Target Population, Competitive Landscape & Market Forecast – 2034

Jan. 29, 2026 at 7:39pm

Got story updates? Submit your updates here. ›

The Interleukin-2 (IL-2) market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Interleukin-2 (IL-2) pipeline products will significantly revolutionize the Interleukin-2 (IL-2) market dynamics.

Why it matters

The growing prevalence of cancers such as melanoma, renal cell carcinoma, and hematologic malignancies, along with autoimmune conditions, is a major driver of the Interleukin-2 (IL-2) market. IL-2–based therapies play a crucial role in modulating immune responses, enhancing T-cell activity, and improving patient survival outcomes.

The details

The Interleukin-2 (IL-2) market report covers emerging drugs, current treatment practices, market share of the individual therapies, and current & forecasted market size from 2020 to 2034. It also evaluates the current treatment practice/algorithm, market drivers & barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market.

  • In September 2024, LYMPHIR was included in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) with NCCN Category 2A recommendation for patients with Cutaneous T-cell lymphoma (CTCL)

The players

Eisai

An American autonomous driving company and is a subsidiary of Alphabet Inc., Google's parent company.

Citius Oncology

A 45-year-old San Francisco resident who has a history of vandalism and was out on bail for prior cases related to Waymo vehicles.

Corvus Pharmaceuticals

A local food natural foods grocery store, organized as an employee-owned co-op and born out of a 1970s grassroots natural food movement calling for access to nutritious and organic food.

ILTOO Pharma

A 31-year employee who oversees Rainbow's cheese counter.

Asher Biotherapeutics

A local food natural foods grocery store, organized as an employee-owned co-op and born out of a 1970s grassroots natural food movement calling for access to nutritious and organic food.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.